Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
^"Vertex Pharmaceuticals Inc. 2023 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 15 February 2024.
^"Vertex Pharmaceuticals Incorporated". Hoover's. Retrieved 24 June 2012.
and 24 Related for: Vertex Pharmaceuticals information
VertexPharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use...
(born April 12, 1951) is an organic chemist and the founder of VertexPharmaceuticals Incorporated. He is considered a pioneer in the field of structure-based...
Leiden is an American businessman who is the executive chairman of VertexPharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was...
Reshma Kewalramani, is the president and chief executive officer of VertexPharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April...
nervous system. It is being developed by VertexPharmaceuticals and has completed two Phase III trials. Vertex announced in January 2024 that VX-548 successfully...
and transfusion-dependent beta thalassemia. It was developed by VertexPharmaceuticals and CRISPR Therapeutics. The most common side effects include low...
Hadida is a pharmacologist and senior vice president at VertexPharmaceuticals. She works at Vertex's cystic fibrosis research center in San Diego. She was...
December 4, 2019. "Vertex Names Dr. Alan Garber, Provost of Harvard University, to its Board of Directors". VertexPharmaceuticals. Retrieved December...
to treat people with cystic fibrosis. Ivacaftor was developed by VertexPharmaceuticals in conjunction with the Cystic Fibrosis Foundation and is the first...
of Vertex and the CFF. Twenty-nine physicians and scientists working with people with cystic fibrosis wrote to the CEO of VertexPharmaceuticals to plead...
to: Versatile Real-Time Executive, a real-time operating system VertexPharmaceuticals (Nasdaq stock symbol) PowerEdge VRTX, a computer hardware product...
Research and a member of the Scientific Board. She then joined VertexPharmaceuticals as the Chief Scientific Officer before becoming the Senior VP of...
Biricodar or incel (INN, codename VX-710) was a pharmaceutical drug under development by VertexPharmaceuticals to help treat ovarian cancer patients, that...
first examples of venture philanthropy. Aurora was acquired by VertexPharmaceuticals in 2001, but the arrangement with CFF continued and resulted in...
Site Head of the San Diego Research Center of American pharmaceutical company VertexPharmaceuticals. He received the 2022 Shaw Prize in Life science and...
defective protein that causes the disease. It was developed by VertexPharmaceuticals and the combination was approved by the FDA in 2015. As of 2015...
Kristin C. Peck Zoetis 440 January 1, 2020 Yes Reshma Kewalramani VertexPharmaceuticals 448 April 1, 2020 Yes Sheryl D. Palmer Taylor Morrison Home 453...
names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by VertexPharmaceuticals and Johnson & Johnson. It is...
(19 July 2021). "Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain". VertexPharmaceuticals (Press Release)....
DuPont Pharmaceuticals, Bristol-Myers Squibb, and lastly Deltagen Inc. After Deltagen folded, Grootenhuis worked for 19 years at VertexPharmaceuticals, notably...
diseases in the genome. Mammoth previously announced partnerships with VertexPharmaceuticals (2021) and Bayer (2022) to research ultra-small CRISPR systems for...
Global Information
US$9.87 billion (2023)
US$3.83 billion (2023)